READ-ONLY DIGITIZATION RESULT
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2-Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase III EMERALD Trial.
J Clin Oncol · 2025-Apr-10 · PMID 39787453
Panel Panel_A提取完成待 EXE 对齐验证
Time to QoL deterioration
FIG 4. Kaplan-Meier curves for patient-reported QoL, showing time to QoL deterioration, defined as ≥10-point decrease from baseline in the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Module C30. Generated from data for the QoL analysis set (n = 437). HR and 95% CI were calculated using the stratified Cox proportional hazards model. HR, hazard ratio; QoL, quality of life.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 2 | 2026-07-18T20:19:39+00:00 |